Clopidogrel: Clinical Trials

727 trials of Clopidogrel, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

435 completed, 146 unknown, 53 recruiting, 48 terminated. 299 Phase 4, 158 Phase 3, 84 Phase 2, 82 Phase 1, 67 Not applicable.

By phase and status

PhaseTrialsStatus
Phase 4299Completed 170, Unknown 68, Recruiting 23, Terminated 18, Not yet recruiting 10, Withdrawn 10
Phase 3158Completed 91, Unknown 34, Terminated 13, Recruiting 12, Withdrawn 4, Active not recruiting 3, Not yet recruiting 1
Phase 284Completed 60, Unknown 14, Terminated 5, Recruiting 2, Active not recruiting 1, Not yet recruiting 1, Withdrawn 1
Phase 182Completed 68, Terminated 6, Unknown 6, Recruiting 2
Not applicable67Completed 30, Unknown 18, Recruiting 8, Terminated 5, Active not recruiting 3, Not yet recruiting 2, Withdrawn 1
Early Phase 13Completed 2, Recruiting 1

Follow Clopidogrel: new trials by email Literature Review of Clopidogrel trials Research Report on Clopidogrel

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Spontaneous Coronary Artery Dissection - AntipLatelet Therapy Intensity in Guided coNservative Management (SCAD-ALIGN) Trial
Acetylsalicylic acid ASA, ASA plus Clopidogrel - SCAD, ACS (Acute Coronary Syndrome)
Phase 4Not yet recruitingUniversitätsklinikum Hamburg-Eppendorf35182027-03-012026-10-16
A Pilot Study to Investigate Platelet Reactivity in Patients With Elevated Lipoprotein(a) and Its Response to Antiplatelet Therapy
Aspirin, Clopidogrel - Cardiovascular Prevention
Not applicableNot yet recruitingFrançois MACH602026-11-012026-07-22
Short-Term Dual Antiplatelet Therapy With Early Transi-tion to Low-dose Antiplatelet Monotherapy Using Ti-cagRelor in Chronic Coronary Artery Disease
Ticagrelor 60 mg, clopidogrel 75 mg - Chronic Coronary Syndrome
Phase 4Not yet recruitingUniversity of Messina10002026-11-012026-09-15
A Clinical Trial of Antiplatelets in Psoriasis
Aspirin, Clopidogrel, Placebo - Psoriasis (PsO), Psoriatic Arthritis (PsA)
Phase 4Not yet recruitingNYU Langone Health602026-09-012026-08-05
Prevalence of CYP2C19 Genetic Polymorphisms Among Egyptian Patients Receiving Clopidogrel Following PCI
Clopidogrel - Acute Coronary Syndrome
Enrolling by invitationOctober 6 University10002026-08-012026-10-21
BEACON-AA: Apixaban With or Without Clopidogrel in Stroke Patients With Atrial Fibrillation and Cerebral Atherosclerosis
Apixaban, Clopidogrel - Stroke, Ischemic
Phase 4RecruitingYonsei University5862026-07-142026-10-16
Efficacy and Safety of Indobufen, Aspirin, Cilostazol and Clopidogrel in the Treatment of Ischemic Stroke
indubufen, aspirin, clopidogrel, cilostazol - Acute Ischemic Stroke
Not yet recruitingNanfang Hospital, Southern Medical University20002026-07-012026-05-22
HR-MRI-Directed Tirofiban Therapy for Late-Window Acute Ischemic Stroke (TIAN)
Tirofiban, dual antiplatelet therapy - Stroke, Acute, Stroke, Ischemic
Phase 3RecruitingWeifang Medical University4582026-06-222026-06-25
Duration of Dual Anti-Platelet Therapy in Chronic Limb Threatening Ischemia After Distal Revascularization
Clopidogrel 75 mg/day, Placebo Clopidogrel - CLTI Defined as Rutherford Category 4 or 5
Phase 3RecruitingFondation Hôpital Saint-Joseph6142026-06-122026-06-24
Platelet Aggregation Function-Guided De-Escalation Antiplatelet Therapy in Patients With Acute Ischemic Stroke
Clopidogrel, Aspirin - Ischemic Stroke, Transient Ischemic Attack
Phase 4Not yet recruitingSichuan Provincial People's Hospital38362026-06-012026-06-12
Adjuvant Clopidogrel in Staphylococcus Aureus Bacteremia
Clopidogrel, No antiplatelet treatment - Bacteremia Due to Staphylococcus Aureus
Phase 2Not yet recruitingFundación Pública Andaluza para la gestión de la Investigación en Sevilla2302026-06-012026-02-05
The Pharmacokinetics and Pharmacodynamics Study of Evategrel CG-0255 Besylate)and Plavix® in Healthy Participants
CG-0255 Besylate for Injection, CG-0255 Besylate Capsule, Clopidogrel - Acute Coronary Syndromes (ACS), Recent Myocardial Infarction
Phase 1RecruitingShanghai CureGene Pharmaceutical Co., Ltd.1362026-06-012026-06-29
Study of the Long-term Effects of P2Y12 Inhibitor Monotherapy and Coagulation Markers After Percutaneous Coronary Angioplasty.
Clopidogrel, Ticagrelor, Prasugrel - Coronary Artery Disease, Percutaneous Coronary Intervention
Phase 3RecruitingCardiocentro Ticino3552026-04-202026-05-13
Testing a New Treatment Strategy to Improve Secondary Stroke Prevention for Older Adults: The STROKE75+ Trial
Edoxaban 15 mg, Aspirin or clopidogrel - Stroke, Ischemic
Phase 3Not yet recruitingSunnybrook Health Sciences Centre12042026-04-012026-03-06
Aspirin 50mg vs 100mg Combined With P2Y12 Inhibitor After PCI
Aspirin, P2Y12 inhibitor - Coronary Artery Disease, Acute Coronary Syndromes
Not applicableRecruitingJilin University26402026-03-012026-10-01
Multicenter Trial of Antithrombotic Strategies in Acute Coronary Syndrome With Coronary Artery Ectasia
Aspirin 100 mg, Clopidogrel 75 mg, Rivaroxaban 15 mg - Coronary Artery Ectasia, Acute Coronary Syndromes (ACS)
Phase 4RecruitingInstituto Nacional de Cardiologia Ignacio Chavez3262026-02-112026-04-09
Clopidogrel vs. Aspirin for Cardiovascular Risk Reduction in Patients With S. Aureus Bacteremia
Clopidogrel, Aspirin - Staphylococcus Aureus Endocarditis, Staphylococcus Aureus Septicemia
Phase 4RecruitingTodd C. Lee MD MPH FIDSA3002026-01-152026-09-24
Acetyl-leucine in Post-stroke Ataxia
Acetyl-Leucine, Placebo, Clopidogrel 75 Mg Oral Tablet - Ischemic Stroke
Phase 3RecruitingKafrelsheikh University2002025-12-012025-12-10
A EUROpean Randomized Study on Blood-thinners and Cholesterol-lowering Treatments to Prevent Future Vascular Events in People With Covert Brain Infarcts (CBI)
acetylsalicyclic acid (ASA), Clopidogrel, Rosuvastatin - Covert Brain Infarction
Phase 3RecruitingAarhus University Hospital16522025-11-262025-12-04
to Evaluate the Safety and the Pharmacokinetic and Pharmacodynamic Interactions Between JP-1366 and Clopidogrel, Aspirin, Atorvastatin and Apixaban
JP-1366 and clopidogrel, JP-1366 and aspirin, JP-1366 and atorvastatin - Drug Drug Interaction (DDI)
Phase 1RecruitingOnconic Therapeutics Inc.962025-11-172025-12-04

Showing 20 of 727. Sign in to see all of them.

Conditions studied

Coronary Artery Disease (166)  ·  Acute Coronary Syndrome (102)  ·  Ischemic Stroke (61)  ·  Myocardial Infarction (53)  ·  Stroke (47)  ·  Cardiovascular Diseases (34)  ·  Coronary Disease (34)  ·  Thrombosis (32)  ·  Peripheral Arterial Disease (27)  ·  Atrial Fibrillation (26)  ·  Myocardial Ischemia (24)  ·  ST Elevation Myocardial Infarction (23)  ·  Atherosclerosis (18)  ·  Hemorrhage (18)  ·  Angina, Stable (17)

Sponsors

Sanofi (26)  ·  AstraZeneca (19)  ·  Eli Lilly and Company (14)  ·  University of Florida (14)  ·  Kafrelsheikh University (10)  ·  Assistance Publique - Hôpitaux de Paris (9)  ·  First Affiliated Hospital of Harbin Medical University (9)  ·  Seoul National University Hospital (9)  ·  University of Patras (9)  ·  Beijing Tiantan Hospital (8)  ·  Ottawa Heart Institute Research Corporation (8)  ·  Samsung Medical Center (8)  ·  Seung-Jung Park (8)  ·  Yonsei University (8)  ·  Boehringer Ingelheim (7)

Countries

United States (181)  ·  China (117)  ·  South Korea (100)  ·  Canada (66)  ·  Germany (59)  ·  France (55)  ·  Italy (50)  ·  United Kingdom (46)  ·  Spain (41)  ·  Netherlands (39)  ·  Brazil (30)  ·  Belgium (28)  ·  Poland (28)  ·  Austria (27)  ·  Greece (26)

Top investigators

Adnan Kastrati, MD (5)  ·  Dominick J Angiolillo, MD, PhD (5)  ·  Glenn Carlson, MD (4)  ·  Joo-Yong Hahn, MD, PhD (4)  ·  Julinda Mehilli, MD (4)  ·  Moo Hyun Kim, MD (4)  ·  Seung-Jung Park, MD, PhD (4)  ·  Dominick J Angiolillo, MD,PhD (3)  ·  Hyeon-Cheol Gwon, MD, PhD (3)

Results publications

PMID 35224730, PMID 31867054, PMID 18190818, PMID 19717846, PMID 40875095, PMID 19923168, PMID 20844485, PMID 2375765, PMID 16731270, PMID 17261652, PMID 20194878, PMID 27902833, PMID 28382371, PMID 28988157, PMID 29632238, PMID 35196863, PMID 37489818, PMID 38551015, PMID 12807523, PMID 15738352, PMID 17418288, PMID 17982182, PMID 19106084, PMID 19324253, PMID 19336502, PMID 20079528, PMID 20231231, PMID 20432394, PMID 20531008, PMID 20650435, PMID 20681275, PMID 21079055, PMID 21545948, PMID 22007612, PMID 22019563, PMID 2203564, PMID 22212857, PMID 22305835, PMID 22795280, PMID 22837373, PMID 23303884, PMID 23517020, PMID 24065443, PMID 24677117, PMID 25173339, PMID 26089177, PMID 27160944, PMID 27480425, PMID 27847338, PMID 28527771

NIH funding

2014 (6), 2015 (5), 2008 (4), 2009 (3), 2023 (3), 2025 (3), U01GM074518 (2), U01HL105198 (2), 1OT2HL156812-01 (1), 1UL1RR025774-01 (1), 2016 (1), 2017 (1), 2019 (1), K23HL105897 (1), K23HL141651 (1)